Wealthfront Advisers
DXCM icon

Wealthfront Advisers’s DexCom DXCM Stock Holding History

Wealthfront Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
20,250
-786
-4% -$52.4K ﹤0.01% 679
2026
Q1 		$1.32M Buy
21,036
+5,572
+36% +$388K ﹤0.01% 669
2025
Q4 		$1.03M Buy
15,464
+4,575
+42% +$296K ﹤0.01% 709
2025
Q3 		$733K Buy
10,889
+343
+3% +$27.1K ﹤0.01% 752
2025
Q2 		$921K Buy
10,546
+1,022
+11% +$80.1K ﹤0.01% 695
2025
Q1 		$650K Sell
9,524
-17,309
-65% -$1.41M ﹤0.01% 738
2024
Q4 		$2.09M Buy
26,833
+6,555
+32% +$485K 0.01% 520
2024
Q3 		$1.36M Sell
20,278
-26,387
-57% -$2.17M ﹤0.01% 591
2024
Q2 		$5.29M Buy
46,665
+1,026
+2% +$130K 0.02% 259
2024
Q1 		$6.33M Sell
45,639
-825
-2% -$104K 0.02% 219
2023
Q4 		$5.77M Buy
46,464
+602
+1% +$61.5K 0.02% 215
2023
Q3 		$4.28M Buy
45,862
+2,673
+6% +$301K 0.02% 241
2023
Q2 		$5.55M Buy
43,189
+8,875
+26% +$1.07M 0.02% 196
2023
Q1 		$3.99M Sell
34,314
-657
-2% -$73.5K 0.02% 248
2022
Q4 		$3.96M Buy
34,971
+2,673
+8% +$293K 0.02% 245
2022
Q3 		$2.6M Buy
32,298
+5,616
+21% +$476K 0.01% 312
2022
Q2 		$1.99M Buy
26,682
+15,318
+135% +$1.4M 0.01% 387
2022
Q1 		$1.45M Sell
11,364
-3,632
-24% -$397K 0.01% 462
2021
Q4 		$2.01M Buy
14,996
+9,376
+167% +$1.35M 0.01% 387
2021
Q3 		$768K Buy
5,620
+3,248
+137% +$410K ﹤0.01% 506
2021
Q2 		$253K Sell
2,372
-420
-15% -$40.3K ﹤0.01% 591
2021
Q1 		$251K Sell
2,792
-6,560
-70% -$616K ﹤0.01% 520
2020
Q4 		$864K Buy
9,352
+940
+11% +$83.9K 0.01% 378
2020
Q3 		$867K Buy
8,412
+952
+13% +$99.5K 0.01% 351
2020
Q2 		$756K Buy
+7,460
New +$667K 0.01% 367

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealthfront Advisers's DXCM Position: Q2 2026 in Review

Wealthfront Advisers reduced its DexCom (DXCM) stake by 3.7% in Q2 2026, selling an estimated $52.4K and leaving 20,250 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Wealthfront Advisers first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.33M in Q1 2024. 662 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Wealthfront Advisers held 20,250 shares of DexCom worth $1.36M as of Q2 2026.
  • Wealthfront Advisers sold 786 DexCom shares in Q2 2026, an estimated $52.4K.
  • DexCom made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #679 holding.
  • Wealthfront Advisers first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Wealthfront Advisers's DexCom position peaked at $6.33M in Q1 2024.
  • 662 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.